Among a population of women seeking short-term reversible contraception (SARC), the decision to try long-acting reversible contraception (LARC) resulted in high continuation rates and substantial protection from unintended pregnancy over 24 months, a recent study found. 916 women aged 18 to 29 years who were seeking pills or injectables in a partially randomized patient preference trial were included. Continuation and unintended pregnancy rates through 24 months was estimated. Researchers found:
- 43% of patients chose randomization, and 57% chose the preference option.
- The 24-month LARC continuation probability was 64.3%, statistically higher than SARC groups (25.5% vs 40.0%).
- The 24-month cumulative unintended pregnancy probabilities were 13.9% (preference-SARC), 11.1% (randomized-SARC), and 4.5% (randomized-LARC).
- LARC satisfaction was high (80% happy/neutral, 73% would use again, 81% would recommend to a friend).
Hubacher D, Spector H, Monteith C, Chen P-L. Not seeking yet trying long-acting reversible contraception: A 24-month randomized trial on continuation, unintended pregnancy, and satisfaction. [Published online ahead of print February 19, 2018]. Contraception. doi:10.1016/j.contraception.2018.02.001.
This Week's Must Reads
Must Reads in Contraception
Bleeding and Spotting with the LNG 13.5 mg IUS, Contraception; ePub 2019 Mar 1; Shimoni, et al
Contraception and Chronic Opioid Prescriptions, Contraception; ePub 2019 Feb 11; Ray-Griffith, et al
Hormonal Contraception & Coexisting Medical Conditions, Obstet Gynecol; ePub 2019 Feb; Allen, et al
Contraceptive Switching & Discontinuation, Am J Obstet Gynecol; ePub 2018 Dec 18; Simmons, et al
Efficacy of a Levonorgestrel 52-mg IU System, Obstet Gynecol; ePub 2018 Dec 4; Teal, et al